USE OF GM CSF AS AN ADJUVANT FOR HEPATITIS B VACCINE

使用转基因 CSF 作为乙型肝炎疫苗的佐剂

• 批准号: 6263807
• 负责人: Thomas G Evans
• 金额: $ 1.48万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6263807
• 关键词: clinical research; colony stimulating factor; drug screening /evaluation; hepatitis B; hepatitis vaccine; human subject; human therapy evaluation

The purpose of this study is to test the safety of and ability of GM-CSF (Leukine, a recombinant human protein made in yeast) to boost the immune response of healthy individuals to the hepatitis B vaccine.

本研究的目的是测试 GM-CSF（白细胞介素，一种由酵母制成的重组人蛋白）增强健康个体对乙型肝炎疫苗免疫反应的安全性和能力。